Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rare acquired bleeding disorders.

H G Watson1, Y L Chee, M Greaves

  • 1Department of Medicine and Therapeutics, University of Aberdeen, Polworth Building, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.

Reviews in Clinical and Experimental Hematology
|February 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis.

Bone marrow transplantation·2024
Same author

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Blood·2019
Same author

Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia.

Leukemia·2018
Same author

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Lung cancer (Amsterdam, Netherlands)·2018
Same author

Haemoglobin Titusville: low oxygen saturations but is the patient hypoxaemic?

QJM : monthly journal of the Association of Physicians·2018
Same author

Measurement of rivaroxaban concentrations demonstrates lack of clinical utility of a PT, dPT and APTT test in estimating levels.

International journal of laboratory hematology·2018
Same journal

Genomics in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Infections in hematologic patients: the future.

Reviews in clinical and experimental hematology·2006
Same journal

Thrombotic problems in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Prophylaxis and treatment of bacterial infections: do we need new strategies?

Reviews in clinical and experimental hematology·2006
Same journal

Recent developments in new and old viral infections.

Reviews in clinical and experimental hematology·2006
Same journal

Microbiologic consequences of new approaches to managing hematologic malignancies.

Reviews in clinical and experimental hematology·2006
See all related articles

This review covers rare acquired bleeding disorders, focusing on less common coagulation inhibitors and other uncommon hemorrhagic conditions. Understanding these rare causes is crucial for effective diagnosis and treatment.

Area of Science:

  • Hematology
  • Internal Medicine
  • Pathology

Background:

  • Accurate diagnosis of bleeding causes is essential for optimal therapy.
  • Clinicians are familiar with common hemorrhagic syndromes but less so with rare acquired conditions.
  • Rare bleeding disorders often involve inhibitors of coagulation factors or platelet function, frequently immunoglobulin-based.

Purpose of the Study:

  • To review less common inhibitors of coagulation and hemostasis.
  • To describe important but rare acquired hemorrhagic disorders.
  • To enhance clinical awareness of uncommon causes of bleeding.

Main Methods:

  • Literature review of rare acquired coagulation and hemostasis disorders.
  • Focus on less common inhibitor types (e.g., immunoglobulins).

Related Experiment Videos

  • Categorization of disorders by etiology (nutritional, iatrogenic, disease-associated).

    • Main Results:

    • Identified less common inhibitors of coagulation factors and platelet function as significant causes of bleeding.
    • Described rare nutritional, iatrogenic, and disease-associated hemorrhagic disorders.
    • Highlighted the importance of recognizing these uncommon conditions.

    Conclusions:

    • Rare acquired inhibitors and disorders represent an important differential diagnosis for bleeding.
    • Increased clinician awareness of these conditions is needed for accurate diagnosis and management.
    • Further research into the mechanisms and treatment of rare bleeding disorders is warranted.